European Union health agency to investigate post-vaccine menstruation issues
Monday, February 14, 2022 | Tag Cloud Tags: covid-19, EU, Euro, Europe, European Union, News, Worthy News | Learn about our FREE SYNDICATION Service | Sign up for our Worthy Briefs! | Printer Friendly
(Worthy News) – The health agency of the European Union announced Friday that it will investigate reports of menstrual problems following the administration of some COVID-19 vaccines.
The European Medicines Agency’s (EMA) Pharmacovigilance Risk Assessment Committee is “assessing reported cases of heavy menstrual bleeding (heavy periods) and absence of menstruation (amenorrhea) with the COVID-19 vaccines Comirnaty and Spikevax,” according to the press release.
The EMA admitted to previously concluding that there was no “causal link between these vaccines and menstrual disorders” after studying safety summary reports for EU-approved COVID-19 vaccines. [ Source: Just the News (Read More…) ]
Fair Use Notice:This site contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available in our efforts to advance understanding of environmental, political, human rights, economic, democracy, scientific, and social justice issues, etc. We believe this constitutes a 'fair use' of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U.S.C. Section 107, the material on this site is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. For more information go to: http://www.law.cornell.edu/uscode/17/107.shtml. If you wish to use copyrighted material from this site for purposes of your own that go beyond 'fair use', you must obtain permission from the copyright owner.